The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of intratumoral G100, toll-like receptor-4 (TLR4) agonist, therapy in patients with Merkel cell carcinoma (MCC).
 
Shailender Bhatia
Stock and Other Ownership Interests - Halozyme
Honoraria - Genentech; Novartis; Prometheus
Consulting or Advisory Role - Genentech
Speakers' Bureau - Novartis; Prometheus
Research Funding - Bristol-Myers Squibb; EMD Serono; Immune Design; Merck; Novartis; OncoSec
 
Dafina Ibrani
No Relationships to Disclose
 
Natalie Vandeven
No Relationships to Disclose
 
Natalie Miller
No Relationships to Disclose
 
Michi Shinohara
Employment - Dermatopathology Northwest
 
David Byrd
No Relationships to Disclose
 
Upendra Parvathaneni
No Relationships to Disclose
 
Erica Shantha
Patents, Royalties, Other Intellectual Property - none (I)
 
Olga K. Afanasiev
No Relationships to Disclose
 
Michael Donahue
No Relationships to Disclose
 
David M Koelle
Consulting or Advisory Role - Agenus; Eisai
Research Funding - Admedus (Inst); Immune Design (Inst); Sanofi Pasteur (Inst)
Patents, Royalties, Other Intellectual Property - University of Washington
 
Frank James Hsu
Employment - Immune Design; Zyngenia
Leadership - Immune Design; Zyngenia
Stock and Other Ownership Interests - Immune Design; Zyngenia
Patents, Royalties, Other Intellectual Property - Genzyme; Immune Design; Stanford University
Travel, Accommodations, Expenses - Immune Design; Zyngenia
 
Paul Nghiem
No Relationships to Disclose